|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21-22
|
|
pubmed:dateCreated |
2010-5-31
|
|
pubmed:abstractText |
Atherosclerosis is common and myocardial infarction, stroke and peripheral arterial occlusive disease are its devastating complications. Accurate risk prediction is urgently needed. We applied molecular tests to improve early clinical identification of patients threatened by a future course of complicated active atherosclerosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1424-3997
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
29
|
|
pubmed:volume |
140
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
307-13
|
|
pubmed:dateRevised |
2011-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:20458649-Aged,
pubmed-meshheading:20458649-Aged, 80 and over,
pubmed-meshheading:20458649-Cardiovascular Diseases,
pubmed-meshheading:20458649-Cholesterol Ester Transfer Proteins,
pubmed-meshheading:20458649-Clinical Medicine,
pubmed-meshheading:20458649-Female,
pubmed-meshheading:20458649-Humans,
pubmed-meshheading:20458649-Male,
pubmed-meshheading:20458649-Middle Aged,
pubmed-meshheading:20458649-Polymorphism, Single Nucleotide,
pubmed-meshheading:20458649-Switzerland
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A CETP polymorphism improves the diagnostic power of clinical examination in patients with cardiovascular disease.
|
|
pubmed:affiliation |
University Department of Medicine, Kantonsspital Bruderholz, Bruderholz, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
